8,921
Total Claims
$1.1M
Drug Cost
605
Beneficiaries
$1,792
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
+27%
Cost per patient vs peers
$1,792 vs $1,411 avg
+13%
Brand preference vs peers
12.0% vs 10.6% avg
Brand vs Generic
88% generic
Brand: 1,060 claims · $871K
Generic: 7,760 claims · $206K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 144 | $171K |
| Apixaban | 94 | $133K |
| Dulaglutide | 46 | $104K |
| Insulin Glargine,hum.Rec.Anlog | 66 | $62K |
| Empagliflozin | 46 | $58K |
| Mirabegron | 45 | $43K |
| Rivaroxaban | 21 | $27K |
| Budesonide/Formoterol Fumarate | 49 | $26K |
| Insulin Detemir | 20 | $21K |
| Tiotropium Bromide | 19 | $18K |
| Dapagliflozin Propanediol | 11 | $14K |
| Atorvastatin Calcium | 730 | $13K |
| Insulin Degludec | 13 | $13K |
| Gabapentin | 257 | $9,032 |
| Fluticasone Propion/Salmeterol | 13 | $8,952 |
Prescribing Profile
Patient Profile
71
Avg Age
78%
Female
1.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data